CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 engineering of the CYP3A5 *3 locus (rs776746) in human liver cell line HuH-7 (CYP3A5 *3/*3) has led to three CYP3A5 *1 cell lines by deletion of the exon 3B splice junction or point mutation. Cell lines CYP3A5 *1/*3 sd (single d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Metab Dispos
Main Authors: Dorr, Casey R., Remmel, Rory P., Muthusamy, Amutha, Fisher, James, Moriarity, Branden S., Yasuda, Kazuto, Wu, Baolin, Guan, Weihua, Schuetz, Erin G., Oetting, William S., Jacobson, Pamala A., Israni, Ajay K.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518718/
https://ncbi.nlm.nih.gov/pubmed/28533324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.117.076307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados